[Abstract] Antigen-specific T cell-derived induced pluripotent stem cells (iPSCs) 
2. Transfer the other clump onto mitomycin C-treated MEFs or iMatrix-511 coated 12 well-plate for cell proliferation after dissociation using gentle pipetting.
3. Incubate at 37 °C in an incubator with 5% CO2. Day -7
1. Dissociate OP9 cells (around 90% confluent) with 0.25% trypsin-EDTA.
2. Collect dissociated OP9 cells by passing through a cell strainer (size: 100 μm), and seed at 6 x 10 5 cells in a 10 cm dish in 10 ml OP9 medium.
3. Incubate at 37 °C in an incubator with 5% CO2.
Day -5
1. Add 10 ml OP9 medium.
2. Incubate at 37 °C in an incubator with 5% CO2.
Day 0
1. Replace OP9 medium with fresh OP9 medium supplemented with 10 μM Y-27632.
Dissociate human iPS cells (80% confluent) into clumps using a StemPro EZ passage tool
under a stereomicroscope ( Figure 4A ).
3. Collect about 100 clumps ( Figure 4B ) using a P200-pipette under a stereomicroscope and plate them onto an OP9-seeded 10 cm dish.
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Figure 4. Representative NKT-iPSC morphology for iPS-NKT differentiation. NKT-iPSC
were divided into a few clumps using EZ-passage tool and pipetting. A. Colony shape of NKT-iPSC after cut using StemPro EZ-passage tool; B. Small NKT-iPSC clumps were prepared and collected by pipetting and passage into OP9 feeder cells.
Day 1
1. Replace the medium with 20 ml OP9 medium.
Day 9
1. Discard half of the supernatant (media).
2. Add 10 ml OP9 medium.
Day 12
1. Dissociate OP9DLL1 cells (around 90% confluent) with 0.25% trypsin-EDTA.
2. Collect dissociated OP9DLL1 cells by passing through a cell strainer (size: 100 μm), and seed at 2 x 10 6 cells on a 10 cm dish in 10 ml OP9 medium.
Day 13
1. Discard medium and rinse the cells with 10 ml HBSS + .
2. Add 6 ml collagenase (20 mg/ml).
3. Incubate at 37 °C, 45 min in a CO2 incubator.
4. Discard collagenase and rinse the cells with 10 ml D-PBS.
5. Add 6 ml 0.25% trypsin-EDTA.
6. Incubate at 37 °C, 30 min in a CO2 incubator.
7. Add 4 ml OP9 medium and collect dissociated cells passing through a cell strainer (size: 100 μm).
8.
Resuspend the collected cells with 10 ml OP9 medium supplemented with 10 ng/ml of SCF, 5
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Day 16
1. Preparation of mitomycin-C treated OP9DLL1 cells a. Replace medium of OP9DLL1 cells with 6 ml OP9 medium supplemented with 1 μg/ml of mitomycin-C.
b. Incubate for 2 h, at 37 °C, 5% CO2 in a CO2 incubator.
c. Rinse mitomycin-C treated OP9DLL1 cells with D-PBS twice, and add 6 ml OP9 medium.
d. Incubate at 37 °C in an incubator with 5% CO2.
Passage of differentiating iPS-NKT cells.
a. Collect the cells (prepared at Day 13) by pipetting and dissociate by passing through a cell strainer (size: 100 μm).
b. Resuspend collected cells with 10 ml OP9 medium supplemented with10 ng/ml SCF, 5 ng/ml human IL-7 and 5 ng/ml Flt3-ligand and plate onto a mitomycin-C treated OP9DLL1
cell-seeded 10 cm dish.
c. Incubate at 37 °C in an incubator with 5% CO2.
Day 24
2. Collect the dissociated cells by passing through a cell strainer (size: 100 μm), and seed at 2 x 10 6 cells on 10 cm dish in 10 ml OP9 medium.
Day 25
b. Incubate for 2 h at 37 °C, 5% CO2 in a CO2 incubator.
d. Incubate at 37 °C in an incubator with 5% CO2. b. Resuspend collected cells with 10 ml OP9 medium supplemented with 10 ng/ml SCF, 5 ng/ml human IL-7 and 5 ng/ml Flt3-ligand and plate onto a mitomycin-C treated OP9DLL1
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Day 30
1. Add 5 ml OP9 medium supplemented with10 ng/ml SCF, 5 ng/ml human IL-7 and 5 ng/ml Flt3-ligand (total 15 ml).
Day 33
1. Collect the cells by passing through a cell strainer (size: 100 μm). 3. Seed the iPS-NKT cells at 5 x 10 5 cells/well into a 6 well-plate in 2 ml OP9 medium supplemented with 5 ng/ml human IL-7 and 10 ng/ml human IL-15.
4. Incubate at 37 °C in an incubator with 5% CO2.
Day 35, 37, 39 and 41
1. Add 1 ml OP9 medium supplemented with 5 ng/ml human IL-7 and 10 ng/ml human IL-15.
Day 43
1. Collect iPS-NKT cells ( Figure 5 ) by pipetting and passing through a cell strainer (size: 100 μm). 2. Six hours after incubation at 37 °C, 5% CO2 in a CO2 incubator, 100 μl of supernatant is www.bio-protocol.org/e2277 
Data analysis
We performed reprogramming of Vα24 iPS-NKT cells.
5. Mitomycin-C treated MEFs are prepared as previously described (Conner, 2001 ) with a small modification.
a. Replace medium of the MEFs with 6 ml MEF medium supplemented with 1 μg/ml of mitomycin-C.
c. Rinse mitomycin-C treated MEF with D-PBS twice, and add 6 ml MEF medium.
e. Mitomycin C-treated MEFs purchased from ReproCELL can also be used.
6. We usually start with 2-4 x 10 7 mononuclear cells from peripheral blood or cord blood that can be stored in liquid nitrogen until use. PBMCs or CBMCs are cultured in RPMI supplemented with 10% FBS and 100 U/ml of hIL-2 and stimulated with α-GalCer (100 ng/ml) for 10-14 days.
Cells are stained with FITC-conjugated anti-human Va24 antibody followed by anti-FITC MACS beads (Miltenyi Biotech, 10 μl beads to 10 7 cells). According to manufacturer's protocol,
Vα24
+ iNKT cells are positively purified by using an LS column (Miltenyi Biotech, purity > 95%).
Purified Vα24
+ iNKT cells are cultured in complete NKT medium. We usually obtain around 2 million Vα24 + iNKT cells from one donor.
